B-3 (Meiji Seika Pharma/Juntendo University)
N/A
Report date: 2025/01/26 18:20:39
Base Information
Drug NameB-3 (Meiji Seika Pharma/Juntendo University)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJuntendo University
China Registration ClassN/A
Develop Information
Active CompaniesRIKEN Center for Sustainable Resource ScienceTokyo University of ScienceMeiji Seika Pharmatech Co Ltd +[5]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A